Your browser doesn't support javascript.
loading
Controlled Pulmonary Delivery of Carrier-Free Budesonide Dry Powder by Atomic Layer Deposition.
La Zara, Damiano; Sun, Feilong; Zhang, Fuweng; Franek, Frans; Balogh Sivars, Kinga; Horndahl, Jenny; Bates, Stephanie; Brännström, Marie; Ewing, Pär; Quayle, Michael J; Petersson, Gunilla; Folestad, Staffan; van Ommen, J Ruud.
Afiliação
  • La Zara D; Department of Chemical Engineering, Delft University of Technology, Van der Maasweg 9, Delft, 2629HZ, The Netherlands.
  • Sun F; Department of Chemical Engineering, Delft University of Technology, Van der Maasweg 9, Delft, 2629HZ, The Netherlands.
  • Zhang F; Department of Chemical Engineering, Delft University of Technology, Van der Maasweg 9, Delft, 2629HZ, The Netherlands.
  • Franek F; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
  • Balogh Sivars K; Clinical Testing and Precision Medicine, Global Procurement, Operations, AstraZeneca, Gothenburg, Sweden.
  • Horndahl J; Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Bates S; Functional and Mechanistic Safety, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge U.K.
  • Brännström M; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Ewing P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Quayle MJ; New Modalities and Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden.
  • Petersson G; Innovation Strategy and External Liaison, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden.
  • Folestad S; Innovation Strategy and External Liaison, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden.
  • van Ommen JR; Department of Chemical Engineering, Delft University of Technology, Van der Maasweg 9, Delft, 2629HZ, The Netherlands.
ACS Nano ; 15(4): 6684-6698, 2021 04 27.
Article em En | MEDLINE | ID: mdl-33769805

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dióxido de Silício / Budesonida Limite: Humans Idioma: En Revista: ACS Nano Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dióxido de Silício / Budesonida Limite: Humans Idioma: En Revista: ACS Nano Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda